Three primary synchronous malignancies of the uterus, cervix, and fallopian tube: A case report
Multiple primary malignancies can occur in the same organ or in multiple organs or systems. Likewise, they can occur simultaneously or successively. Based on the timing of the diagnosis, they are classified as multiple synchronous (i.e., concurrent) or metachronous (i.e., successive) primary maligna...
Gespeichert in:
Veröffentlicht in: | Medicine (Baltimore) 2018-06, Vol.97 (24), p.e11107-e11107 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e11107 |
---|---|
container_issue | 24 |
container_start_page | e11107 |
container_title | Medicine (Baltimore) |
container_volume | 97 |
creator | Song, Liang Li, Qingli Yang, Kaixuan Yin, Rutie Wang, Danqing |
description | Multiple primary malignancies can occur in the same organ or in multiple organs or systems. Likewise, they can occur simultaneously or successively. Based on the timing of the diagnosis, they are classified as multiple synchronous (i.e., concurrent) or metachronous (i.e., successive) primary malignancies. The vast majority of patients have multiple metachronous malignant tumors; multiple synchronous tumors are rare.
A 63-year-old woman presented with the chief complaint of vaginal fluid discharge for 3 months and abdominal pain for 1 month.
The patient was diagnosed with multiple synchronous primary malignancies: 1) endometrial poorly differentiated serous adenocarcinoma, stage IV; 2) poorly differentiated squamous cell carcinoma of the cervix, stage IB1; and 3) left-sided fallopian tube carcinoma in situ.
After total abdominal hysterectomy, bilateral salpingo-oophorectomy, and comprehensive staging and debulking, the patient was administered eight courses of adjuvant chemotherapy (taxane carboplatin/taxane cisplatin).
After chemotherapy completion, the patient has been undergoing regular follow-up examinations; no recurrence has been noted at 18 months.
It is important to distinguish between multiple synchronous primary malignancies and metastasis of a primary tumor to select the appropriate treatment regimen and to adequately assess the patient's prognosis. When a cancer patient shows clinical manifestations of another tumor, not only metastasis but also the possibility of multiple synchronous primary malignant tumors should be considered. The duration of follow-up in patients with malignant tumors should be extended as much as possible, as the timely detection and treatment of other primary malignant tumors can prolong survival and improve the quality of life. |
doi_str_mv | 10.1097/MD.0000000000011107 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6024067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2055614315</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3558-216d58644d68cb017e8a46b96e12f91abae718c25babce761ca6435fffc4a3403</originalsourceid><addsrcrecordid>eNpdUU1v1DAQtRCILgu_AAn5yKEp_nbCAalqoUVq1Us5WxPvpAl47cVO-vHvSbtLC53LSDNv3sy8R8h7zg44a-yn8-MD9hScc2ZfkAXX0lS6MeolWTAmdGUbq_bIm1J-ziBphXpN9kTTMG4kWxB32WdEusnDGvIdLXfR9znFNBW6hjBcRYh-wEJTR8ce6TRinso-9Zivh9t9CnFFOwghbQaIdJxa_EwPqYeCNOMm5fEteTX3C77b5SX58e3r5dFpdXZx8v3o8KzyUuu6EtysdG2UWpnat4xbrEGZtjHIRddwaAEtr73QLbQereEejJK66zqvQComl-TLlncztWtceYxjhuB2f7kEg_u_E4feXaVrZ5hQzNiZ4OOOIKffE5bRrYfiMQSIOKvhBNPacCVnfZdEbqE-p1Iydo9rOHP31rjzY_fcmnnqw78XPs789WIGqC3gJoVZ5vIrTDeYXY8Qxv6BT9tGVILxmhmuWXVfqeUfMYOanA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2055614315</pqid></control><display><type>article</type><title>Three primary synchronous malignancies of the uterus, cervix, and fallopian tube: A case report</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wolters Kluwer Open Health</source><source>IngentaConnect Free/Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Song, Liang ; Li, Qingli ; Yang, Kaixuan ; Yin, Rutie ; Wang, Danqing</creator><creatorcontrib>Song, Liang ; Li, Qingli ; Yang, Kaixuan ; Yin, Rutie ; Wang, Danqing</creatorcontrib><description>Multiple primary malignancies can occur in the same organ or in multiple organs or systems. Likewise, they can occur simultaneously or successively. Based on the timing of the diagnosis, they are classified as multiple synchronous (i.e., concurrent) or metachronous (i.e., successive) primary malignancies. The vast majority of patients have multiple metachronous malignant tumors; multiple synchronous tumors are rare.
A 63-year-old woman presented with the chief complaint of vaginal fluid discharge for 3 months and abdominal pain for 1 month.
The patient was diagnosed with multiple synchronous primary malignancies: 1) endometrial poorly differentiated serous adenocarcinoma, stage IV; 2) poorly differentiated squamous cell carcinoma of the cervix, stage IB1; and 3) left-sided fallopian tube carcinoma in situ.
After total abdominal hysterectomy, bilateral salpingo-oophorectomy, and comprehensive staging and debulking, the patient was administered eight courses of adjuvant chemotherapy (taxane carboplatin/taxane cisplatin).
After chemotherapy completion, the patient has been undergoing regular follow-up examinations; no recurrence has been noted at 18 months.
It is important to distinguish between multiple synchronous primary malignancies and metastasis of a primary tumor to select the appropriate treatment regimen and to adequately assess the patient's prognosis. When a cancer patient shows clinical manifestations of another tumor, not only metastasis but also the possibility of multiple synchronous primary malignant tumors should be considered. The duration of follow-up in patients with malignant tumors should be extended as much as possible, as the timely detection and treatment of other primary malignant tumors can prolong survival and improve the quality of life.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000011107</identifier><identifier>PMID: 29901630</identifier><language>eng</language><publisher>United States: The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Carcinoma, Endometrioid - drug therapy ; Carcinoma, Endometrioid - pathology ; Carcinoma, Squamous Cell - drug therapy ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - surgery ; Cervix Uteri - pathology ; Chemotherapy, Adjuvant - methods ; Clinical Case Report ; Endometrial Neoplasms - drug therapy ; Endometrial Neoplasms - pathology ; Endometrial Neoplasms - surgery ; Fallopian Tube Neoplasms - drug therapy ; Fallopian Tube Neoplasms - pathology ; Fallopian Tube Neoplasms - surgery ; Fallopian Tubes - pathology ; Female ; Humans ; Hysterectomy - methods ; Middle Aged ; Neoplasms, Multiple Primary - drug therapy ; Neoplasms, Multiple Primary - pathology ; Neoplasms, Multiple Primary - surgery ; Salpingo-oophorectomy - methods ; Uterine Cervical Neoplasms - drug therapy ; Uterine Cervical Neoplasms - pathology ; Uterine Cervical Neoplasms - surgery ; Uterus - pathology</subject><ispartof>Medicine (Baltimore), 2018-06, Vol.97 (24), p.e11107-e11107</ispartof><rights>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><rights>Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3558-216d58644d68cb017e8a46b96e12f91abae718c25babce761ca6435fffc4a3403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024067/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024067/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,862,883,27911,27912,53778,53780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29901630$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Song, Liang</creatorcontrib><creatorcontrib>Li, Qingli</creatorcontrib><creatorcontrib>Yang, Kaixuan</creatorcontrib><creatorcontrib>Yin, Rutie</creatorcontrib><creatorcontrib>Wang, Danqing</creatorcontrib><title>Three primary synchronous malignancies of the uterus, cervix, and fallopian tube: A case report</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>Multiple primary malignancies can occur in the same organ or in multiple organs or systems. Likewise, they can occur simultaneously or successively. Based on the timing of the diagnosis, they are classified as multiple synchronous (i.e., concurrent) or metachronous (i.e., successive) primary malignancies. The vast majority of patients have multiple metachronous malignant tumors; multiple synchronous tumors are rare.
A 63-year-old woman presented with the chief complaint of vaginal fluid discharge for 3 months and abdominal pain for 1 month.
The patient was diagnosed with multiple synchronous primary malignancies: 1) endometrial poorly differentiated serous adenocarcinoma, stage IV; 2) poorly differentiated squamous cell carcinoma of the cervix, stage IB1; and 3) left-sided fallopian tube carcinoma in situ.
After total abdominal hysterectomy, bilateral salpingo-oophorectomy, and comprehensive staging and debulking, the patient was administered eight courses of adjuvant chemotherapy (taxane carboplatin/taxane cisplatin).
After chemotherapy completion, the patient has been undergoing regular follow-up examinations; no recurrence has been noted at 18 months.
It is important to distinguish between multiple synchronous primary malignancies and metastasis of a primary tumor to select the appropriate treatment regimen and to adequately assess the patient's prognosis. When a cancer patient shows clinical manifestations of another tumor, not only metastasis but also the possibility of multiple synchronous primary malignant tumors should be considered. The duration of follow-up in patients with malignant tumors should be extended as much as possible, as the timely detection and treatment of other primary malignant tumors can prolong survival and improve the quality of life.</description><subject>Carcinoma, Endometrioid - drug therapy</subject><subject>Carcinoma, Endometrioid - pathology</subject><subject>Carcinoma, Squamous Cell - drug therapy</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>Cervix Uteri - pathology</subject><subject>Chemotherapy, Adjuvant - methods</subject><subject>Clinical Case Report</subject><subject>Endometrial Neoplasms - drug therapy</subject><subject>Endometrial Neoplasms - pathology</subject><subject>Endometrial Neoplasms - surgery</subject><subject>Fallopian Tube Neoplasms - drug therapy</subject><subject>Fallopian Tube Neoplasms - pathology</subject><subject>Fallopian Tube Neoplasms - surgery</subject><subject>Fallopian Tubes - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Hysterectomy - methods</subject><subject>Middle Aged</subject><subject>Neoplasms, Multiple Primary - drug therapy</subject><subject>Neoplasms, Multiple Primary - pathology</subject><subject>Neoplasms, Multiple Primary - surgery</subject><subject>Salpingo-oophorectomy - methods</subject><subject>Uterine Cervical Neoplasms - drug therapy</subject><subject>Uterine Cervical Neoplasms - pathology</subject><subject>Uterine Cervical Neoplasms - surgery</subject><subject>Uterus - pathology</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUU1v1DAQtRCILgu_AAn5yKEp_nbCAalqoUVq1Us5WxPvpAl47cVO-vHvSbtLC53LSDNv3sy8R8h7zg44a-yn8-MD9hScc2ZfkAXX0lS6MeolWTAmdGUbq_bIm1J-ziBphXpN9kTTMG4kWxB32WdEusnDGvIdLXfR9znFNBW6hjBcRYh-wEJTR8ce6TRinso-9Zivh9t9CnFFOwghbQaIdJxa_EwPqYeCNOMm5fEteTX3C77b5SX58e3r5dFpdXZx8v3o8KzyUuu6EtysdG2UWpnat4xbrEGZtjHIRddwaAEtr73QLbQereEejJK66zqvQComl-TLlncztWtceYxjhuB2f7kEg_u_E4feXaVrZ5hQzNiZ4OOOIKffE5bRrYfiMQSIOKvhBNPacCVnfZdEbqE-p1Iydo9rOHP31rjzY_fcmnnqw78XPs789WIGqC3gJoVZ5vIrTDeYXY8Qxv6BT9tGVILxmhmuWXVfqeUfMYOanA</recordid><startdate>20180601</startdate><enddate>20180601</enddate><creator>Song, Liang</creator><creator>Li, Qingli</creator><creator>Yang, Kaixuan</creator><creator>Yin, Rutie</creator><creator>Wang, Danqing</creator><general>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</general><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180601</creationdate><title>Three primary synchronous malignancies of the uterus, cervix, and fallopian tube: A case report</title><author>Song, Liang ; Li, Qingli ; Yang, Kaixuan ; Yin, Rutie ; Wang, Danqing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3558-216d58644d68cb017e8a46b96e12f91abae718c25babce761ca6435fffc4a3403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Carcinoma, Endometrioid - drug therapy</topic><topic>Carcinoma, Endometrioid - pathology</topic><topic>Carcinoma, Squamous Cell - drug therapy</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>Cervix Uteri - pathology</topic><topic>Chemotherapy, Adjuvant - methods</topic><topic>Clinical Case Report</topic><topic>Endometrial Neoplasms - drug therapy</topic><topic>Endometrial Neoplasms - pathology</topic><topic>Endometrial Neoplasms - surgery</topic><topic>Fallopian Tube Neoplasms - drug therapy</topic><topic>Fallopian Tube Neoplasms - pathology</topic><topic>Fallopian Tube Neoplasms - surgery</topic><topic>Fallopian Tubes - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Hysterectomy - methods</topic><topic>Middle Aged</topic><topic>Neoplasms, Multiple Primary - drug therapy</topic><topic>Neoplasms, Multiple Primary - pathology</topic><topic>Neoplasms, Multiple Primary - surgery</topic><topic>Salpingo-oophorectomy - methods</topic><topic>Uterine Cervical Neoplasms - drug therapy</topic><topic>Uterine Cervical Neoplasms - pathology</topic><topic>Uterine Cervical Neoplasms - surgery</topic><topic>Uterus - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Song, Liang</creatorcontrib><creatorcontrib>Li, Qingli</creatorcontrib><creatorcontrib>Yang, Kaixuan</creatorcontrib><creatorcontrib>Yin, Rutie</creatorcontrib><creatorcontrib>Wang, Danqing</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Song, Liang</au><au>Li, Qingli</au><au>Yang, Kaixuan</au><au>Yin, Rutie</au><au>Wang, Danqing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Three primary synchronous malignancies of the uterus, cervix, and fallopian tube: A case report</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2018-06-01</date><risdate>2018</risdate><volume>97</volume><issue>24</issue><spage>e11107</spage><epage>e11107</epage><pages>e11107-e11107</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>Multiple primary malignancies can occur in the same organ or in multiple organs or systems. Likewise, they can occur simultaneously or successively. Based on the timing of the diagnosis, they are classified as multiple synchronous (i.e., concurrent) or metachronous (i.e., successive) primary malignancies. The vast majority of patients have multiple metachronous malignant tumors; multiple synchronous tumors are rare.
A 63-year-old woman presented with the chief complaint of vaginal fluid discharge for 3 months and abdominal pain for 1 month.
The patient was diagnosed with multiple synchronous primary malignancies: 1) endometrial poorly differentiated serous adenocarcinoma, stage IV; 2) poorly differentiated squamous cell carcinoma of the cervix, stage IB1; and 3) left-sided fallopian tube carcinoma in situ.
After total abdominal hysterectomy, bilateral salpingo-oophorectomy, and comprehensive staging and debulking, the patient was administered eight courses of adjuvant chemotherapy (taxane carboplatin/taxane cisplatin).
After chemotherapy completion, the patient has been undergoing regular follow-up examinations; no recurrence has been noted at 18 months.
It is important to distinguish between multiple synchronous primary malignancies and metastasis of a primary tumor to select the appropriate treatment regimen and to adequately assess the patient's prognosis. When a cancer patient shows clinical manifestations of another tumor, not only metastasis but also the possibility of multiple synchronous primary malignant tumors should be considered. The duration of follow-up in patients with malignant tumors should be extended as much as possible, as the timely detection and treatment of other primary malignant tumors can prolong survival and improve the quality of life.</abstract><cop>United States</cop><pub>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>29901630</pmid><doi>10.1097/MD.0000000000011107</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0025-7974 |
ispartof | Medicine (Baltimore), 2018-06, Vol.97 (24), p.e11107-e11107 |
issn | 0025-7974 1536-5964 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6024067 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wolters Kluwer Open Health; IngentaConnect Free/Open Access Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Carcinoma, Endometrioid - drug therapy Carcinoma, Endometrioid - pathology Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - pathology Carcinoma, Squamous Cell - surgery Cervix Uteri - pathology Chemotherapy, Adjuvant - methods Clinical Case Report Endometrial Neoplasms - drug therapy Endometrial Neoplasms - pathology Endometrial Neoplasms - surgery Fallopian Tube Neoplasms - drug therapy Fallopian Tube Neoplasms - pathology Fallopian Tube Neoplasms - surgery Fallopian Tubes - pathology Female Humans Hysterectomy - methods Middle Aged Neoplasms, Multiple Primary - drug therapy Neoplasms, Multiple Primary - pathology Neoplasms, Multiple Primary - surgery Salpingo-oophorectomy - methods Uterine Cervical Neoplasms - drug therapy Uterine Cervical Neoplasms - pathology Uterine Cervical Neoplasms - surgery Uterus - pathology |
title | Three primary synchronous malignancies of the uterus, cervix, and fallopian tube: A case report |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T15%3A33%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Three%20primary%20synchronous%20malignancies%20of%20the%20uterus,%20cervix,%20and%20fallopian%20tube:%20A%20case%20report&rft.jtitle=Medicine%20(Baltimore)&rft.au=Song,%20Liang&rft.date=2018-06-01&rft.volume=97&rft.issue=24&rft.spage=e11107&rft.epage=e11107&rft.pages=e11107-e11107&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000011107&rft_dat=%3Cproquest_pubme%3E2055614315%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2055614315&rft_id=info:pmid/29901630&rfr_iscdi=true |